Literature DB >> 14522961

CEACAM1, a cell-cell adhesion molecule, directly associates with annexin II in a three-dimensional model of mammary morphogenesis.

Julia Kirshner1, Detlef Schumann, John E Shively.   

Abstract

The epithelial cell adhesion molecule CEACAM1 (carcinoembryonic antigen cell adhesion molecule-1) is down-regulated in colon, prostate, breast, and liver cancer. Here we show that CEACAM1-4S, a splice form with four Ig-like ectodomains and a short cytoplasmic domain (14 amino acids), directly associates with annexin II, a lipid raft-associated molecule, which is also down-regulated in many cancers. Annexin II was identified using a glutathione S-transferase pull-down assay in which the cytoplasmic domain of CEACAM-4S was fused to glutathione S-transferase, the fusion protein was incubated with cell lysates, and isolated proteins were sequenced by mass spectrometry. The interaction was confirmed first by reciprocal immunoprecipitations using anti-CEACAM1 and anti-annexin II antibodies and second by confocal laser microscopy showing co-localization of CEACAM1 with annexin II in mammary epithelial cells grown in Matrigel. In addition, CEACAM1 co-localized with p11, a component of the tetrameric AIIt complex at the plasma membrane, and with annexin II in secretory vesicles. Immobilized, oriented peptides from the cytoplasmic domain of CEACAM1-4S were shown to directly associate with bovine AIIt, which is 98% homologous to human AIIt, with average KD values of about 30 nM using surface plasmon resonance, demonstrating direct binding of functionally relevant AIIt to the cytoplasmic domain of CEACAM1-4S.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522961     DOI: 10.1074/jbc.M309115200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Hepatic Insulin Clearance: Mechanism and Physiology.

Authors:  Sonia M Najjar; Germán Perdomo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

2.  HLA-G is found in lipid rafts and can act as a signaling molecule.

Authors:  Martina Comiskey; Kenneth E Domino; Carol M Warner
Journal:  Hum Immunol       Date:  2006-11-03       Impact factor: 2.850

3.  Anti-annexin II antibody is associated with thrombosis and/or pregnancy morbidity in antiphospholipid syndrome and systemic lupus erythematosus with thrombosis.

Authors:  Wen Ao; Hui Zheng; Xiao-Wei Chen; Yan Shen; Cheng-De Yang
Journal:  Rheumatol Int       Date:  2010-03-13       Impact factor: 2.631

4.  Mutational analysis of the cytoplasmic domain of CEACAM1-4L in humanized mammary glands reveals key residues involved in lumen formation: stimulation by Thr-457 and inhibition by Ser-461.

Authors:  Chunxia Li; Charng-Jui Chen; John E Shively
Journal:  Exp Cell Res       Date:  2008-12-30       Impact factor: 3.905

5.  Role of Ceacam1 in VEGF induced vasculogenesis of murine embryonic stem cell-derived embryoid bodies in 3D culture.

Authors:  Angel Gu; Walter Tsark; Kathryn V Holmes; John E Shively
Journal:  Exp Cell Res       Date:  2009-03-10       Impact factor: 3.905

6.  A33 antigen displays persistent surface expression.

Authors:  Margaret E Ackerman; Cecile Chalouni; Michael M Schmidt; Vivek V Raman; Gerd Ritter; Lloyd J Old; Ira Mellman; K Dane Wittrup
Journal:  Cancer Immunol Immunother       Date:  2008-07       Impact factor: 6.968

7.  Direct interaction of tumor suppressor CEACAM1 with beta catenin: identification of key residues in the long cytoplasmic domain.

Authors:  Lan Jin; Yun Li; Charng-Jui Chen; Mark A Sherman; Keith Le; John E Shively
Journal:  Exp Biol Med (Maywood)       Date:  2008-04-29

8.  The short isoform of the CEACAM1 receptor in intestinal T cells regulates mucosal immunity and homeostasis via Tfh cell induction.

Authors:  Lanfen Chen; Zhangguo Chen; Kristi Baker; Elizabeth M Halvorsen; Andre Pires da Cunha; Magdalena B Flak; Georg Gerber; Yu-Hwa Huang; Shuhei Hosomi; Janelle C Arthur; Ken J Dery; Takashi Nagaishi; Nicole Beauchemin; Kathryn V Holmes; Joshua W K Ho; John E Shively; Christian Jobin; Andrew B Onderdonk; Lynn Bry; Howard L Weiner; Darren E Higgins; Richard S Blumberg
Journal:  Immunity       Date:  2012-11-01       Impact factor: 31.745

Review 9.  Biological modulation by lectins and their ligands in tumor progression and metastasis.

Authors:  Susumu Nakahara; Avraham Raz
Journal:  Anticancer Agents Med Chem       Date:  2008-01       Impact factor: 2.505

10.  Sinonasal epithelial wound resealing in an in vitro model: inhibition of wound closure with IL-4 exposure.

Authors:  Sarah K Wise; Kyle A Den Beste; Elizabeth K Hoddeson; Charles A Parkos; Asma Nusrat
Journal:  Int Forum Allergy Rhinol       Date:  2013-03-06       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.